Tyrosine kinase inhibitors - PDFSEARCH.IO - Document Search Engine

Tyrosine kinase inhibitors
Results: 62

#	Item
11	Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed Add to Reading List Source URL: michorlab.dfci.harvard.edu Language: English - Date: 2011-08-23 09:57:30 Quinazolines Lung cancer Amines Tyrosine kinase receptors Ethers T790M Erlotinib EGFR inhibitors Epidermal growth factor receptor Gefitinib Afatinib Targeted therapy
12	· Non-Small Cell Lung Cancer · Antiangiogenesis and Future Combinations with Anti-Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer Edward S. Kim, MD Add to Reading List Source URL: gotoper-com.s3.amazonaws.com Language: English - Date: 2015-09-10 13:42:25
13	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV® (nintedanib) capsules, for oral use I Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-10-16 13:43:09 Chemistry Breakthrough therapy Medicine Piperazines Organic chemistry Tyrosine kinase inhibitors Nintedanib Lactams Pirfenidone Adverse effect Nitrazepam
14	A historical overview of protein kinases and their targeted small molecule inhibitors Add to Reading List Source URL: www.brimr.org Language: English - Date: 2015-08-01 12:59:02 Biology Cell biology Protein kinases Signal transduction Biochemistry Cell signaling Phosphorus Serine/threonine-specific protein kinase Non-receptor tyrosine kinase Protein phosphorylation Kinase Mitogen-activated protein kinase
15	Tyrosine kinase inhibitors quantification in human plasma M. Helvenstein1,3, R. Conotte2,3, J-M. Colet2,3, B. Blankert1,3 1Laboratory of Pharmaceutical Analysis, Faculty of medicine and pharmacy, University of Mons, Pla Add to Reading List Source URL: hosting.umons.ac.be Language: English - Date: 2013-03-08 03:24:56
16	technology offer A Cobalt-Based Strategy for Tumour Targeting by EGFR-Inhibitors Background The development of receptor tyrosine-kinase inhibitors (TKIs) in recent decades was a major step forward in cancer treatment. Ho Add to Reading List Source URL: forschung.univie.ac.at Language: English - Date: 2014-04-23 07:44:21
17	Microsoft PowerPoint - 2006_ACS_Fall_SF_Renick_poster_Sept8 Add to Reading List Source URL: www.biopredict.com Language: English - Date: 2006-11-28 17:36:33 Tyrosine kinase Organic chemistry Imatinib Src FYN Protein kinase Protein kinase inhibitors Pyrimidines Pyridines Piperazines
18	What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral Add to Reading List Source URL: www.euikcs.com Language: English - Date: 2014-05-13 15:09:11 Organofluorides Quinolines Tyrosine kinase inhibitors Angiology Foretinib Cabozantinib Kidney cancer Vascular endothelial growth factor AKT Medicine Biology Cyclopropanes
19	New target: FGFR & c-MET Laurence Albiges Gustave Roussy Institute, Dana-Farber Cancer Institute New target : FGFR, c-MET Add to Reading List Source URL: www.euikcs.com Language: English - Date: 2015-05-04 13:05:47 Organofluorides Angiology Growth factors Tyrosine kinase inhibitors Pyridines Vascular endothelial growth factor Sunitinib End point of clinical trials Sorafenib Chemistry Organic chemistry Biology
20	ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors Add to Reading List Source URL: www.brimr.org Language: English - Date: 2014-06-28 13:34:52 Oncogenes Signal transduction Protein kinases Protein domains ErbB Epidermal growth factor receptor ERBB3 Tyrosine kinase Receptor tyrosine kinase Biology Cell biology Tyrosine kinase receptors